{"version":"1.0","provider_name":"Pharma Trend","provider_url":"https:\/\/pharma-trend.com\/en","author_name":"Business Wire","author_url":"https:\/\/pharma-trend.com\/en\/author\/business\/","title":"Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122 - Pharma Trend","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"cK1PGBHgsQ\"><a href=\"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/\">Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pharma-trend.com\/en\/torus-biosystems-previews-orbit-pcr-at-idweek\/embed\/#?secret=cK1PGBHgsQ\" width=\"600\" height=\"338\" title=\"&#8220;Torus Biosystems Previews Orbit PCR\u2122 at IDWeek\u2122&#8221; &#8212; Pharma Trend\" data-secret=\"cK1PGBHgsQ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pharma-trend.com\/en\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"qPCR redefined to advance research and innovation MEDFORD, Mass.&#8211;(BUSINESS WIRE)&#8211;Torus Biosystems (\u201cTorus\u201d or the \u201cCompany\u201d) today announced that it would be introducing Orbit PCR\u2122 for Research Use Only (RUO) applications at IDWeek\u2122 in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible ... [Read more...]","thumbnail_url":"https:\/\/mms.businesswire.com\/media\/20221020005061\/en\/1606482\/21\/Torus_ID_cmyk.jpg"}